| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |